SCHEMBL21031224

SCHEMBL21031224

c1ccc(-c2cccc(-c3cc(-c4cccc(-c5c6ccccc6nc6sc7ccccc7c56)c4)nc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.36
▸ KMT2A Q03164 6/20 0.36
▸ ALDH1A1 P00352 6/20 0.36
▸ MAPT P10636 6/20 0.36
▸ HPGD P15428 5/20 0.36
▸ KDM4E B2RXH2 5/20 0.36
▸ LMNA P02545 5/20 0.36
▸ GLA P06280 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ NTSR1 P30989 1/20 0.35
▸ ABCG2 Q9UNQ0 4/20 0.35
▸ ACHE P22303 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ NFKB1 P19838 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ NFKB2 Q00653 2/20 0.33
▸ RELA Q04206 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031446 0.98 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25847652 0.96 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21031221 0.96 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21032053 0.95 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21030961 0.95 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25847640 0.95 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21031450 0.94 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21031222 0.93 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21031228 0.93 ADORA2A (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21031449 0.92 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ALDH1A1 865/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ALDH1A1 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback